The Informed Consent Action Network (ICAN) has uncovered alarming insights regarding a U.S. military program, known as DARPA INTERCEPT, that focuses on self-spreading vaccines. According to documents obtained through a Department of Defense request, there is evidence that animal trials for this controversial vaccine approach have been successful. ICAN asserts that the next step involves injecting terminally ill patients.
Autonomous Therapeutics, a biotech company, has reportedly conducted successful tests of these self-spreading vaccines in monkeys. Their aim is to create what they describe as “synthetic immune systems.” This effort is part of a broader initiative where engineered viruses, termed therapeutic interfering particles (TIPs), are designed to spread genetic material from one individual to another. ICAN highlights that these TIPs could potentially integrate into patients’ DNA, leading to permanent alterations.
Previously, ICAN brought attention to studies related to these vaccines. Recent findings show that DARPA planned to develop not only these biologically engineered particles but also computer models to predict their spread within populations. Such technology raises significant concern, as once these particles are released, there is no guarantee of control over their movement or effects.
Documents reveal that a contract was awarded to Autonomous Therapeutics back in 2016, aimed at replicating human-like conditions for examining pathogens’ evolution. Leor Weinberger, a co-founder of the company, has tested these TIPs on rhesus monkeys and now seeks to inject them into terminally ill patients, particularly those with HIV. ICAN warns that this method blurs the lines between medical treatment and reckless biological experimentation.
The self-spreading vaccine concept is not new. It has origins in wildlife medicine from the 1980s, intended to control diseases through engineered viruses. However, the recent military involvement, such as with DARPA’s INTERCEPT program, has intensified scrutiny. Critics argue that the unpredictability of spreading these vaccines poses a direct conflict with established public health values, particularly the principle of informed consent.
ICAN is actively pursuing legal action against the federal government concerning grants provided to Autonomous Therapeutics. They have also filed a Freedom of Information Act request for reports related to the INTERCEPT program. The organization urges public awareness about this troubling research, emphasizing that the implications of these developments could lead to unforeseen genetic consequences in populations.
"*" indicates required fields
